About argenx BV
United in our commitment to improve the lives of patients
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Boston, MA
- Founded
- 2008
- Company type
- Public Company
- Company profile name
- argenx
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.
Specialties
- Oncology
- Autoimmune diseases
- Rare Diseases
- Antibody based medicines
- Immunotherapy
- Myasthenia Gravis
- Immunology
- Pemphigus Vulgaris
- Immune Thrombocytopenia
- Acute Myeloid Leukemia
- high-risk myelodysplastic syndromes
- and chronic inflammatory demyelinating polyneuropathy
Company locations
33 Arch Street, Suite 3201, Boston, MA 02110, US
Technologiepark 30, Ghent, 9052, BE
3-19-23 Minami-Azabu, Minato-KU, Tokyo , 106-0047, JP
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 123,944
- People linked to this company
- 2,277
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.